CD8A and neoplasm: In a more recent study, 100–200 μm-thick PCTS from a breast cancer PDX model used in imaging assays revealed that CD49a integrin expression increased the motility of CD8+ TILs that were near tumor cells, potentially distracting them from tumor antigen recognition [40].